Controlling initial biodegradation of magnesium by a biocompatible strontium phosphate conversion coating

Magnesium implants are known to degrade rapidly after implantation, which can lead to hydrogen gas accumulation and adverse biological effects. While prior research has shown that magnesium alloys offer biodegradable properties beneficial for orthopedic and cardiovascular applications, the initial rapid degradation rate remains a significant challenge. It was already known that protective coatings could influence the degradation profile of magnesium. However, no prior work had resolved how to effectively control the early-stage degradation without compromising biocompatibility. This gap motivated the exploration of alternative coating methods that could delay initial corrosion while maintaining cell compatibility. The need for a biocompatible and protective coating is clear, as current strategies often fail to balance degradation control and tissue interaction. This study builds on established knowledge of magnesium corrosion mechanisms and biocompatible materials. It introduces a novel approach to managing degradation kinetics while preserving cell viability. The development of a conversion coating that is both protective and biocompatible is a critical step toward improving magnesium-based implants.

The aim of this study was to develop a simple and effective strontium phosphate (SrP) conversion coating to control the initial degradation of magnesium implants. The specific problem addressed is the rapid corrosion of magnesium in biological environments, which can lead to hydrogen gas accumulation and tissue damage. The motivation for this research stems from the need to improve the biocompatibility and degradation control of magnesium-based implants. The study focuses on how processing temperature affects coating morphology and protective properties. The researchers propose that by adjusting the processing temperature, they can optimize the coating's ability to slow magnesium degradation. The study also investigates the impact of the coating on cell proliferation and differentiation. The goal is to ensure that the coating does not hinder the biological function of surrounding tissues. This approach aims to bridge the gap between material protection and biological compatibility.

The researchers used a strontium phosphate conversion coating process to modify magnesium surfaces. The coating process was carried out at different temperatures, specifically 40 °C and 80 °C, to evaluate their effects on coating properties. The morphology of the coatings was analyzed using scanning electron microscopy. X-ray diffraction was used to identify the crystalline phases formed during the coating process. The protective ability of the coatings was assessed by measuring the anodic dissolution rate of magnesium in minimum essential medium. The coatings were immersed in MEM for 14 days to simulate in vivo conditions. The integrity of the coatings after immersion was examined to determine their durability. Cell proliferation and differentiation were studied using human mesenchymal stem cells to evaluate biocompatibility. The study combined material characterization with biological testing to assess both protective and biocompatible properties.

The SrP coatings produced at 80 °C were primarily composed of strontium apatite (SrAp) with a granular surface morphology. These coatings exhibited a high degree of crystallinity and the highest protective ability against magnesium degradation. The protective effect was attributed to the inhibition of anodic dissolution in minimum essential medium. After 14 days of immersion, the SrAp coating remained largely intact with minimal surface corrosion. Coatings produced at 40 °C showed lower crystallinity and reduced protective properties. The study found that the coating morphology and crystallinity were strongly influenced by the processing temperature. Human mesenchymal stem cells cultured on the SrP-coated surfaces showed proliferation rates similar to those on pure magnesium. The SrP coatings did not significantly affect cell differentiation or viability. These findings suggest that SrP coatings can effectively control early-stage magnesium degradation while maintaining biocompatibility.

The study suggests that SrP conversion coatings can effectively control the initial degradation of magnesium implants. The protective ability of the coatings is closely related to their crystallinity and morphology, which are influenced by processing temperature. Coatings produced at 80 °C showed the best performance in terms of both protection and biocompatibility. The SrAp phase formed at higher temperatures provided a durable barrier against magnesium corrosion. The study also indicates that SrP coatings do not hinder cell proliferation or differentiation. These findings support the use of SrP coatings as a promising strategy for improving magnesium-based implants. The authors propose that this approach could reduce hydrogen gas evolution and tissue damage associated with rapid magnesium degradation. The results highlight the importance of optimizing coating parameters to achieve both material protection and biological compatibility.